Browsing U.S. Classifications

Reports by CambridgeIP

Blood Glucose Monitors and Wireless Communication
Telehealth

More
Recent Trends in Nanotechnology Patenting: 2005 to May 2011
Nano1

More
First Solar, Inc. (Nasdaq: FSLR) - A Focus on the Technology Fundamentals
Solar

More
Patenting flatland: Graphene - Exploitation challenges and opportunities
Graphene_patent_landscape_report

More
Patenting Flatland: Graphene
Naturereport2

More
Pandemic Influenza (H1N1 & H5N1) patenting trends
Hn51

More

Results display:

Refine search:

You need to login or signup to refine your search

Login | Signup

1-10 of 1,717 patent results

Amphiphilic imidazolinium derivatives

U.S. Patent US5736395 | Filed: 05/19/1997 | Issued: 04/07/1998
Assignee(s): Megabios Corporation | Inventor(s): Timothy D. Heath + 1 | Agent(s): McDonnell Boehnen Hulbert & Berghoff | Examiner(s): Floyd D. Higel
Amphiphiles containing an imidazdinium ring system are provided that are non-toxic to the host mammal. The amphiphiles are used to produce liposomes useful as carriers for delivering macromolecules...

Method for culturing t lineage precursor cells under conditions of high oxygen concentration

U.S. Patent US5792655 | Filed: 09/11/1995 | Issued: 08/11/1998
Assignee(s): Japan Tobacco, Inc. | Inventor(s): Yoshihiro Watanabe | Agent(s): Birch, Stewart, Kolasch & Birch, LLP | Examiner(s): Marian C. Knode
The present invention provides culture methods of T lineage precursor cells comprising a step of culturing the T lineage precursor cells under a condition that a dissolved oxygen concentration in t...

Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens

U.S. Patent US5994126 | Filed: 06/17/1994 | Issued: 11/30/1999
Assignee(s): The Rockefeller University | Inventor(s): Ralph M. Steinman + 2 | Agent(s): Morgan & Finnegan, L.L.P. | Examiner(s): Lankford, Jr.; Leon B.
A method for producing proliferating cultures of dendritic cell precursors is provided. Also provided is a method for producing mature dendritic cells in culture from the proliferating dendritic ce...

Monoclonal antibodies to ceftiofur

U.S. Patent US5908781 | Filed: 12/10/1996 | Issued: 06/01/1999
Assignee(s): The United States of America as represented by the Secretary of Agriculture | Inventor(s): Larry H. Stanker + 3 | Agent(s): Randall E. Deck | Examiner(s): Lila Feisee
Hybridoma cell lines have been generated which produce and secrete monoclonal antibodies which selectively bind to the ceftiofur. These hybridomas may be obtained by using as an immunization agent ...

Monoclonal antibody to human mx protein mxa

U.S. Patent US6180102 | Filed: 10/02/1998 | Issued: 01/30/2001
Assignee(s): Kyowa Hakko Kogyo Co., Ltd. + 1 | Inventor(s): Nobuo Hanai + 4 | Agent(s): Nixon & Vanderhye P.C. | Examiner(s): Marianne P. Allen
This invention provides a monoclonal antibody which recognizes an epitope corresponding to amino acids 10 to 220, amino acids 221 to 297, or amino acids 469 to 662, counting from the N-terminus of ...

Anti-fas ligand antibody and assay method using the anti-fas ligand antibody

U.S. Patent US6114507 | Filed: 05/17/1996 | Issued: 09/05/2000
Assignee(s): Mochida Pharmaceutical Co., Ltd. + 1 | Inventor(s): Kamon Shirakawa + 4 | Agent(s): Birch, Stewart, Kolasch & Birch, LLP | Examiner(s): Jeffrey Stucker
An anti-Fas ligand antibody capable of suppressing Fas ligand-induced apoptosis to a high degree, especially humanized antibodies having less antigenecity to human, and a method for assaying the Fa...

Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody

U.S. Patent US6228360 | Filed: 08/19/1998 | Issued: 05/08/2001
Assignee(s): Ajinomoto Co., Inc. | Inventor(s): Man Sung Co + 1 | Agent(s): Oblon, Spivak, McClelland, Maier & Neustadt, P.C. | Examiner(s): Phillip Gambel
Anti-thrombotic agents containing humanized antibodies which bind to von Willebrand factor.

Ip-10/mig receptor designated cxcr3, antibodies, nucleic acids, and methods of use therefor

U.S. Patent US6184358 | Filed: 03/31/1997 | Issued: 02/06/2001
Assignee(s): Millennium Pharmaceuticals, Inc. + 1 | Inventor(s): Marcel Loetscher + 3 | Agent(s): Hamilton, Brook, Smith & Reynolds, P.C. | Examiner(s): Prema Mertz
The present invention relates to proteins or polypeptides, referred to herein as isolated and/or recombinant mammalian (e.g., human) IP-10/Mig receptor proteins designated CXC Chemokine Receptor 3 ...

Humanized antibodies reactive with l-selectin

U.S. Patent US6210671 | Filed: 12/27/1995 | Issued: 04/03/2001
Assignee(s): Protein Design Labs, Inc. | Inventor(s): Man Sung Co | Agent(s): Townsend & Townsend & Crew | Examiner(s): Phillip Gambel
Humanized immunoglobulins specifically reactive with L-selectin are prepared employing recombinant DNA technology for use in e.g., treatment of inflammatory disorders.

Transgenic non-human animals for producing heterologous antibodies

U.S. Patent US6300129 | Filed: 12/02/1996 | Issued: 10/09/2001
Assignee(s): GenPharm International | Inventor(s): Nils Lonberg + 1 | Agent(s): Townsend & Townsend & Crew | Examiner(s): Karen M. Hauda
The invention relates to transgenic non-human animals capable of producing heterologous antibodies and methods for producing human sequence antibodies which bind to human antigens with substantial ...